| Literature DB >> 26467027 |
Josette S Y Chor1, Alexander C Vlantis2, Tam-Lin Chow3, Siu-Chung Fung4, Fiona Y H Ng5, Chi-Hung Lau6, Amy B W Chan7, Luen-Cheung Ho8, Wing-Hang Kwong9, Mandy N S Fung10, Eddy W H Lam2,11, Kwong-Lin Mak12, Holly C Y Lam1, Amy S Y Kok3, Wendy C S Ho13, Apple C M Yeung13, Paul K S Chan13.
Abstract
HPV plays a role in the development of a portion of head and neck squamous cell carcinoma (HNSCC), but only limited information on its role in southern Chinese population is available. A multicenter case-control study was conducted. HPV type, viral integration, E6/7 mRNA expression status, and TP53 mutation were determined. A total of 228 HNSCC were recruited including 137 (60.1%) oral SCC, 34 (14.9%) oropharyngeal SCC, 31 (13.6%) laryngeal SCC, 21 (9.2%) hypopharyngeal SCC, and 5 (2.2%) lip and paranasal sinus SCC. High-risk HPV infection was found in 7.5% (17/228) of HNSCC, but only a small proportion of samples had evidence of viral integration (5.3%, 12/228) or E6/7 mRNA expression (4.4%, 10/228). HPV infection with oncogenic phenotype (integration and E6/7 mRNA expression) was significantly more common in oropharyngeal SCC than controls (9/34, 26.5% vs. 0/42, 0.0%, P < 0.001). Smoking showed a significant association with HNSCC, oropharyngeal SCC, and laryngeal SCC. TP53 mutation was associated with HNSCC (P < 0.001). Older age, TP53 mutation, and HPV16 infection with oncogenic phenotypes were independently associated factors for HNSCC with odds ratios of 1.03 (1.02-1.05), 3.38 (1.71-6.66), and 9.19 (1.13-74.68), respectively. High-risk HPV infection of head and neck mucosa is not uncommon in the Hong Kong population. This study found that 26-30% of oropharyngeal carcinoma was associated with HPV infection, mostly HPV16, and that smoking which predisposes to TP53 mutations was another important risk factor.Entities:
Keywords: China; HPV; Hong Kong; head and neck cancer; oral cavity cancer; oropharyngeal cancer
Mesh:
Substances:
Year: 2015 PMID: 26467027 DOI: 10.1002/jmv.24405
Source DB: PubMed Journal: J Med Virol ISSN: 0146-6615 Impact factor: 2.327